BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MedImmune, Inc. (MEDI) Founder, Wayne T. Hockmeyer, Ph.D., Retires


6/19/2007 1:34:28 PM

GAITHERSBURG, Md., June 19 /PRNewswire/ -- MedImmune, Inc. today announced that its founder, Wayne T. Hockmeyer, Ph.D., is retiring as president of MedImmune Ventures, Inc. Dr. Hockmeyer also stepped down as the company's chairman upon AstraZeneca's completion of its tender offer to acquire all outstanding shares of MedImmune common stock.

Dr. Hockmeyer commented: "I am honored to have been a part of building one of the most successful biotechnology companies in the world. The last 19 years at MedImmune have been exciting, professionally stimulating and remarkably productive. I believe the company, now as a part of AstraZeneca, will continue to be successful in developing new and promising therapies that improve healthcare. I also expect MedImmune to continue to grow as one of the premier biotech companies, adding new jobs, playing an important leadership role in the scientific community, and continuing its involvement as a dedicated corporate citizen."

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians, and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com .

MedImmune, Inc.

CONTACT: Kate Barrett for MedImmune, Inc., +1-301-398-4320



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES